Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Triangle, Inc. on April 8, 2025, covering corporate governance events occurring between April 8 and April 11, 2025. The company is an emerging growth company incorporated in Delaware, with its common stock (HCTI) trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding executive and board changes and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial indicators.
Material Changes
The filing reports significant changes to the Company's executive leadership and Board of Directors:
- Resignation of CFO: Mr. Thyagarajan Ramachandran resigned as Chief Financial Officer, effective April 10, 2025. The resignation was not due to any disagreement regarding operations, policies, or practices.
- Appointment of New CFO: Mr. David Ayanoglou was appointed Chief Financial Officer, effective April 10, 2025.
- Resignation of Director: Mr. Shibu Kizhakevilayil resigned from the Board of Directors, effective April 10, 2025, with no disagreement cited.
- Appointment of New Director: Ms. Sujatha Ramesh was appointed as an executive director, effective April 10, 2025, in addition to her existing role as Chief Operating Officer.
Guidance, Outlook, and Management Commentary
Compensation and Employment Terms:
- Mr. Ayanoglou's employment is on an at-will basis with an annual base salary of $278,000.
- He is eligible for the Company's bonus program (goals to be agreed upon), equity incentive plans, and standard employee benefits.
- Termination for violation of the agreement may occur without notice or compensation, subject to over-dues.
- Ms. Ramesh will be compensated in accordance with the Company's standard Board compensation policies disclosed in the Form 10-K filed on March 31, 2025.
Management Background:
- Mr. Ayanoglou brings over 23 years of experience in corporate finance, M&A, and financial reporting, including 13 years at Open Text and prior roles at KPMG LLP.
- Ms. Ramesh has over 25 years of senior executive experience, most recently as Global Head of Strategic Initiatives at Citigroup (2006–2024).
Risks and Contingencies: The filing states there are no disagreements related to the resignations and no undisclosed arrangements regarding the appointments. No specific financial risks or contingencies are detailed in this document.
Investor Verification Checklist
- Verify the transition plan for financial reporting and internal controls following the CFO change.
- Review the full Employment Agreement (Exhibit 10.1) for specific bonus targets and equity grant details.
- Confirm the impact of the Board composition change on the Company's governance structure.
- Check the March 31, 2025 Form 10-K for the specific Board compensation policies applicable to Ms. Ramesh.